Stakeholders responding to recent draft guidance from the US Food and Drug Administration (FDA) on the use of minimal ...
Real-world data is increasingly used to optimize trial design, reduce recruitment burden, and support regulatory decisions, but adoption remains uneven due to challenges around data quality, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results